Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

2000 • 1,463 citations

Elevated tumour necrosis factor-alpha (TNF-α) biological activity in psoriatic skin lesions

1994 • 481 citations

Treatment with anti-tumor necrosis factor α (TNF-α) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions

2000 • 228 citations

Cytokines in psoriasis

1999 • 174 citations

Correlated increases of tumour necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients relationships with disease severity

1994 • 165 citations

Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis.

1997 • 150 citations

Rapid onset of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis after starting tumor necrosis factor ? receptor IgG1-Fc fusion complex therapy

2001 • 141 citations

Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis

1999 • 130 citations

Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis.

1999 • 129 citations

Inhibitors of tumor necrosis factor for rheumatoid arthritis.

1999 • 125 citations

Inhibitors of tumor necrosis factor: New treatment options for rheumatoid arthritis

1999 • 29 citations

The role of tumor necrosis factor antagonism in clinical practice.

1999 • 28 citations